NO20055688L - Organiske forbindelser - Google Patents

Organiske forbindelser

Info

Publication number: NO20055688L
Authority: NO; Norway
Prior art keywords: compounds; organic compounds; muscarinic; meanings; receptor
Prior art date: 2003-05-02

Application number

NO20055688A

Other languages

English (en)

Norwegian (no)

Other versions

NO20055688D0 (no

Inventor

Gurdip Bhalay

Stephen Paul Collingwood

Brian Cox

Urs Baettig

Nicholas James Devereux

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-02

Filing date

2005-12-01

Publication date

2006-01-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20055688(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-10-24 Priority claimed from GB0324887A external-priority patent/GB0324887D0/en

2005-12-01 Application filed by Novartis Ag filed Critical Novartis Ag

2005-12-01 Publication of NO20055688D0 publication Critical patent/NO20055688D0/no

2006-01-09 Publication of NO20055688L publication Critical patent/NO20055688L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

NO20055688A 2003-05-02 2005-12-01 Organiske forbindelser NO20055688L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0310232		2003-05-02
GB0324887A GB0324887D0 (en)	2003-10-24	2003-10-24	Organic compounds
PCT/EP2004/004605 WO2004096800A2 (fr)	2003-05-02	2004-04-30	Composes organiques

Publications (2)

Publication Number	Publication Date
NO20055688D0 NO20055688D0 (no)	2005-12-01
NO20055688L true NO20055688L (no)	2006-01-09

Family

ID=33420896

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055688A NO20055688L (no)	2003-05-02	2005-12-01	Organiske forbindelser

Country Status (31)

Country	Link
US (2)	US20070060563A1 (fr)
EP (1)	EP1631569B1 (fr)
JP (1)	JP4416786B2 (fr)
KR (1)	KR100896544B1 (fr)
AR (1)	AR044134A1 (fr)
AT (1)	ATE440840T1 (fr)
AU (1)	AU2004234069B2 (fr)
BR (1)	BRPI0410238A (fr)
CA (1)	CA2523436C (fr)
CL (1)	CL2004000918A1 (fr)
CO (1)	CO5700782A2 (fr)
CY (1)	CY1109655T1 (fr)
DE (1)	DE602004022805D1 (fr)
DK (1)	DK1631569T3 (fr)
EC (1)	ECSP056134A (fr)
ES (1)	ES2331185T3 (fr)
HR (1)	HRP20050933A2 (fr)
IL (1)	IL171591A (fr)
IS (1)	IS2746B (fr)
MA (1)	MA27775A1 (fr)
MX (1)	MXPA05011739A (fr)
MY (1)	MY142652A (fr)
NO (1)	NO20055688L (fr)
NZ (1)	NZ542995A (fr)
PE (1)	PE20050465A1 (fr)
PL (1)	PL1631569T3 (fr)
PT (1)	PT1631569E (fr)
RU (1)	RU2363700C2 (fr)
SI (1)	SI1631569T1 (fr)
TW (1)	TWI340139B (fr)
WO (1)	WO2004096800A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2239546B1 (es) *	2004-03-15	2006-12-01	Almirall Prodesfarma, S.A.	Nuevos esteres de quinuclidina cuaternizados.
GB0410712D0 (en)	2004-05-13	2004-06-16	Novartis Ag	Organic compounds
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0428416D0 (en) *	2004-12-24	2005-02-02	Novartis Ag	Organic compounds
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
EP1900737A1 (fr) *	2006-08-31	2008-03-19	Novartis AG	Polymorphe de (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
EP1894568A1 (fr) *	2006-08-31	2008-03-05	Novartis AG	Composées pharmaceutiques destinées au traitement des maladies inflammatoires ou obstructives des bronches
TW200825084A (en)	2006-11-14	2008-06-16	Astrazeneca Ab	New compounds 521
CA2672446A1 (fr) *	2006-12-19	2008-06-26	Astrazeneca Ab	Derives quinuclidinol utilises en tant qu'antagonistes du recepteur muscarinique
EP1950196A1 (fr) *	2007-01-29	2008-07-30	Boehringer Ingelheim Pharma GmbH & Co. KG	Procédé de fabrication d'hexafluorophosphates d'ammonium
CN101796026B (zh)	2007-09-07	2013-10-23	施万制药	可用作毒蕈碱受体拮抗剂的含胍化合物
US8017617B2 (en) *	2007-12-14	2011-09-13	Theravance, Inc.	Amidine-containing compounds useful as muscarinic receptor antagonists
JP5584138B2 (ja)	2008-01-11	2014-09-03	ノバルティスアーゲー	キナーゼ阻害剤としてのピリミジン類
EP2315589A4 (fr) *	2008-05-13	2013-09-11	Astrazeneca Ab	PRODUIT PHARMACEUTIQUE COMPRENANT UN ANTAGONISTE DU RÉCEPTEUR MUSCARINIQUE ET UN AGONISTE DES béta2-ADRÉNOCEPTEURS
GB0808709D0 (en) *	2008-05-13	2008-06-18	Astrazeneca Ab	New combination 295
WO2009138707A1 (fr) *	2008-05-13	2009-11-19	Astrazeneca Ab	Dérivés de quinuclidine utilisés comme antagonistes des récepteurs muscariniques m3
US20090326004A1 (en)	2008-06-03	2009-12-31	Ranbaxy Laboratories Limited	Muscarinic receptor antagonists
GB0811100D0 (en) *	2008-06-17	2008-07-23	Astrazeneca Ab	New combination
WO2009153536A1 (fr) *	2008-06-17	2009-12-23	Argenta Discovery Limited	Dérivés de 1-aza-bicyclo [2.2.2] octane utiles en tant qu’antagonistes des récepteurs muscariniques
KR20130087405A (ko) *	2010-06-22	2013-08-06	키에시 파르마슈티시 엣스. 피. 에이.	알칼로이드 아미노에스테르 유도체 및 이의 의약 조성물
UY33597A (es)	2010-09-09	2012-04-30	Irm Llc	Compuestos y composiciones como inhibidores de la trk
WO2012034095A1 (fr)	2010-09-09	2012-03-15	Irm Llc	Composés et compositions comme inhibiteurs de trk
AU2012220572A1 (en)	2011-02-25	2013-08-29	Irm Llc	Compounds and compositions as trk inhibitors
JP2011195593A (ja) *	2011-06-30	2011-10-06	Astrazeneca Ab	ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体
RU2628082C2 (ru) *	2011-12-30	2017-08-14	КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.	Хинуклидиновые эфиры 1-азагетероциклилуксусной кислоты в качестве антимускариновых средств, способ их получения и их лекарственные композиции
CN104470515B (zh)	2012-05-03	2016-12-07	圣路易斯药学院	用于增加神经营养肽的组合物和方法
TWI647227B (zh) *	2013-02-28	2019-01-11	日商安斯泰來製藥股份有限公司	２－醯胺噻唑衍生物或其鹽
CZ306791B6 (cs)	2013-10-29	2017-07-12	Zentiva, K.S.	Průmyslově využitelný způsob přípravy aklidinium bromidu o vysoké čistotě
PT108370B (pt) *	2015-03-30	2018-10-25	Hovione Farm S A	Processo de preparação de brometo de aclidínio
PL3111978T3 (pl)	2015-07-03	2022-01-24	Novartis Ag	Inhalator przystosowany do odczytu informacji przechowywanych w środkach przechowywania danych pojemnika

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1219606A (en) *	1968-07-15	1971-01-20	Rech S Et D Applic Scient Soge	Quinuclidinol derivatives and preparation thereof
DK534178A (da) *	1977-12-16	1979-06-17	Interx Research Corp	Anticholinerge midler med sektrtionshaemmende virkning
IT1230881B (it) *	1989-06-20	1991-11-08	Angeli Inst Spa	Derivati del r(-) 3-chinuclidinolo
ES2165768B1 (es) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
AU2001271027B2 (en) *	2000-07-11	2005-07-07	Msd K.K.	Ester derivatives
UA75626C2 (en) *	2000-12-28	2006-05-15	Almirall Prodesfarma Ag	Quinuclidine derivatives and medicinal compositions containing the same
UA76571C2 (en) *	2001-12-20	2006-08-15		Derivatives of 1-alkyl-1-azoniabicyclo [2.2.2.]octanecarbamate and use thereof as antagonists of muscarin receptor
GB0424284D0 (en) *	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
EP1900737A1 (fr) *	2006-08-31	2008-03-19	Novartis AG	Polymorphe de (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide

2004
- 2004-04-29 AR ARP040101468A patent/AR044134A1/es not_active Application Discontinuation
- 2004-04-30 CA CA2523436A patent/CA2523436C/fr not_active Expired - Fee Related
- 2004-04-30 PE PE2004000435A patent/PE20050465A1/es not_active Application Discontinuation
- 2004-04-30 DK DK04730519T patent/DK1631569T3/da active
- 2004-04-30 MX MXPA05011739A patent/MXPA05011739A/es active IP Right Grant
- 2004-04-30 PT PT04730519T patent/PT1631569E/pt unknown
- 2004-04-30 US US10/554,558 patent/US20070060563A1/en not_active Abandoned
- 2004-04-30 JP JP2006505341A patent/JP4416786B2/ja not_active Expired - Fee Related
- 2004-04-30 DE DE602004022805T patent/DE602004022805D1/de not_active Expired - Lifetime
- 2004-04-30 SI SI200431277T patent/SI1631569T1/sl unknown
- 2004-04-30 WO PCT/EP2004/004605 patent/WO2004096800A2/fr not_active Ceased
- 2004-04-30 KR KR1020057020776A patent/KR100896544B1/ko not_active Expired - Fee Related
- 2004-04-30 TW TW093112339A patent/TWI340139B/zh not_active IP Right Cessation
- 2004-04-30 ES ES04730519T patent/ES2331185T3/es not_active Expired - Lifetime
- 2004-04-30 AU AU2004234069A patent/AU2004234069B2/en not_active Ceased
- 2004-04-30 HR HR20050933A patent/HRP20050933A2/xx not_active Application Discontinuation
- 2004-04-30 RU RU2005137360/04A patent/RU2363700C2/ru not_active IP Right Cessation
- 2004-04-30 CL CL200400918A patent/CL2004000918A1/es unknown
- 2004-04-30 BR BRPI0410238-0A patent/BRPI0410238A/pt not_active IP Right Cessation
- 2004-04-30 EP EP04730519A patent/EP1631569B1/fr not_active Expired - Lifetime
- 2004-04-30 AT AT04730519T patent/ATE440840T1/de active
- 2004-04-30 PL PL04730519T patent/PL1631569T3/pl unknown
- 2004-04-30 MY MYPI20041637A patent/MY142652A/en unknown
- 2004-04-30 NZ NZ542995A patent/NZ542995A/en not_active IP Right Cessation
2005
- 2005-10-27 IL IL171591A patent/IL171591A/en not_active IP Right Cessation
- 2005-11-01 EC EC2005006134A patent/ECSP056134A/es unknown
- 2005-11-03 CO CO05112195A patent/CO5700782A2/es not_active Application Discontinuation
- 2005-11-08 MA MA28583A patent/MA27775A1/fr unknown
- 2005-11-30 IS IS8158A patent/IS2746B/is unknown
- 2005-12-01 NO NO20055688A patent/NO20055688L/no not_active Application Discontinuation
2009
- 2009-10-20 US US12/582,291 patent/US8168654B2/en not_active Expired - Fee Related
- 2009-11-25 CY CY20091101230T patent/CY1109655T1/el unknown

Also Published As

Publication number	Publication date
KR100896544B1 (ko)	2009-05-07
ECSP056134A (es)	2006-04-19
CL2004000918A1 (es)	2005-02-11
US20100041887A1 (en)	2010-02-18
KR20060015572A (ko)	2006-02-17
MA27775A1 (fr)	2006-02-01
ATE440840T1 (de)	2009-09-15
AR044134A1 (es)	2005-08-24
RU2363700C2 (ru)	2009-08-10
NO20055688D0 (no)	2005-12-01
DE602004022805D1 (de)	2009-10-08
HRP20050933A2 (en)	2006-12-31
ES2331185T3 (es)	2009-12-23
PE20050465A1 (es)	2005-07-18
JP4416786B2 (ja)	2010-02-17
JP2006525267A (ja)	2006-11-09
IS8158A (is)	2005-11-30
DK1631569T3 (da)	2009-11-23
TW200505920A (en)	2005-02-16
CY1109655T1 (el)	2014-08-13
WO2004096800A3 (fr)	2005-01-06
WO2004096800A2 (fr)	2004-11-11
RU2005137360A (ru)	2006-07-27
HK1087704A1 (en)	2006-10-20
AU2004234069A1 (en)	2004-11-11
BRPI0410238A (pt)	2006-05-16
PL1631569T3 (pl)	2010-02-26
CA2523436C (fr)	2011-11-01
US8168654B2 (en)	2012-05-01
EP1631569B1 (fr)	2009-08-26
US20070060563A1 (en)	2007-03-15
IS2746B (is)	2011-08-15
CO5700782A2 (es)	2006-11-30
NZ542995A (en)	2009-02-28
MY142652A (en)	2010-12-15
MXPA05011739A (es)	2006-01-26
PT1631569E (pt)	2009-11-26
CA2523436A1 (fr)	2004-11-11
SI1631569T1 (sl)	2010-01-29
IL171591A (en)	2010-11-30
TWI340139B (en)	2011-04-11
EP1631569A2 (fr)	2006-03-08
AU2004234069B2 (en)	2008-02-21

Publication	Publication Date	Title
NO20055688L (no)	2006-01-09	Organiske forbindelser
NO20061406L (no)	2006-08-25	Organiske forbindelser
TW200519106A (en)	2005-06-16	Organic compounds
NO20074093L (no)	2008-02-07	Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav
NO20060324L (no)	2006-05-18	[1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni
NO20076197L (no)	2008-02-29	Nye 2-azetidinonderivater anvendbare i behandling av hyperlipidemiske tilstander
NO20072371L (no)	2007-07-12	Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
NO20074592L (no)	2007-10-19	Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister
CY1116885T1 (el)	2017-04-05	Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
GB0305152D0 (en)	2003-04-09	Organic compounds
NO20076195L (no)	2008-02-27	Nye 2-azetidinonderivater for behandling av hyperlipidemiske sykdommer
NO20076254L (no)	2008-02-27	Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander
NO20074258L (no)	2007-11-27	Pyridin-2-karboksamidderivater som MGLUR5 antagonister
NO20076138L (no)	2008-02-27	Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander
NO20081217L (no)	2008-04-15	Nye benzotiazolonderivater
NO20076196L (no)	2008-02-29	Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander
NO20092689L (no)	2009-09-14	Quinuclidinolderivater som muskarin reseptorantagonister
NO20091626L (no)	2009-05-04	MGLUR5-modulatorer
SE0401762D0 (sv)	2004-07-05	Novel compounds
MXPA05013823A (es)	2006-02-28	Derivados de pirrolidinio y piperidino como ligandos para el receptor m3 muscarinico.
NO20061363L (no)	2006-04-24	Pyrazolo- og imidazo- pyrimidinderivater
BRPI0519292A2 (pt)	2009-01-06	compostos orgÂnicos
GB0428416D0 (en)	2005-02-02	Organic compounds
NO20064351L (no)	2006-11-20	Caspaseinhibitorer og anvendelser derav
ATE450262T1 (de)	2009-12-15	Harnstoff-derivate als calcium-rezeptor- modulatoren

Legal Events

Date	Code	Title	Description
2012-11-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application